Amgen's Humira Biosimilar Wins FDA Staff Support
Amgen's proposed biosimilar of AbbVie's immunosuppressant Humira is a close match of the mega-blockbuster, U.S. Food and Drug Administration staff said Friday, setting the stage for an advisory committee endorsement....To view the full article, register now.
Already a subscriber? Click here to view full article